113 related articles for article (PubMed ID: 34318822)
1. Carbon nanohorns as nanocontainers for cisplatin: insight into their interaction with the plasma membranes of normal and breast cancer cells.
Almeida ER; Dos Santos HF; Capriles PVSZ
Phys Chem Chem Phys; 2021 Aug; 23(30):16376-16389. PubMed ID: 34318822
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the Releasing Processes of Pt(II)-Based Anticancer Drugs from Oxidized Carbon Nanohorn: An In Silico Study.
Almeida ER; Capriles PVSZ; Dos Santos HF
J Phys Chem B; 2022 Jun; ():. PubMed ID: 35670834
[TBL] [Abstract][Full Text] [Related]
3. Chemically Modified Carbon Nanohorns as Nanovectors of the Cisplatin Drug: A Molecular Dynamics Study.
Almeida ER; De Souza LA; De Almeida WB; Dos Santos HF
J Chem Inf Model; 2020 Feb; 60(2):500-512. PubMed ID: 31738559
[TBL] [Abstract][Full Text] [Related]
4. Carbon nanotube capsules enhance the in vivo efficacy of cisplatin.
Guven A; Villares GJ; Hilsenbeck SG; Lewis A; Landua JD; Dobrolecki LE; Wilson LJ; Lewis MT
Acta Biomater; 2017 Aug; 58():466-478. PubMed ID: 28465075
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics of carbon nanohorns and their complexes with cisplatin in aqueous solution.
Almeida ER; De Souza LA; De Almeida WB; Dos Santos HF
J Mol Graph Model; 2019 Jun; 89():167-177. PubMed ID: 30903984
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells.
Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z
AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292
[TBL] [Abstract][Full Text] [Related]
7. The Permeation Mechanism of Cisplatin Through a Dioleoylphosphocholine Bilayer*.
Ruano L; Cárdenas G; Nogueira JJ
Chemphyschem; 2021 Jun; 22(12):1251-1261. PubMed ID: 33829637
[TBL] [Abstract][Full Text] [Related]
8. Magnetically Targeted Nanocapsules for PAA-Cisplatin-Conjugated Cores in PVA/SPIO Shells via Surfactant-Free Emulsion for Reduced Nephrotoxicity and Enhanced Lung Cancer Therapy.
Chiang CS; Tseng YH; Liao BJ; Chen SY
Adv Healthc Mater; 2015 May; 4(7):1066-75. PubMed ID: 25656800
[TBL] [Abstract][Full Text] [Related]
9. Modeling the Cellular Uptake of Functionalized Carbon Nanohorns Loaded with Cisplatin through a Breast Cancer Cell Membrane.
Almeida ER; Goliatt PVZC; Dos Santos HF; Picaud F
Mol Pharm; 2024 Jan; 21(1):38-52. PubMed ID: 37646561
[TBL] [Abstract][Full Text] [Related]
10. Translocation Processes of Pt(II)-Based Drugs through Human Breast Cancer Cell Membrane:
Almeida ER; Goliatt PVZC; Dos Santos HF; Picaud F
J Chem Inf Model; 2023 Oct; 63(19):6141-6155. PubMed ID: 37751589
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity.
Xu Y; Han X; Li Y; Min H; Zhao X; Zhang Y; Qi Y; Shi J; Qi S; Bao Y; Nie G
ACS Nano; 2019 Nov; 13(11):13445-13455. PubMed ID: 31670945
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
[TBL] [Abstract][Full Text] [Related]
13. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin@US-tube carbon nanocapsules for enhanced chemotherapeutic delivery.
Guven A; Rusakova IA; Lewis MT; Wilson LJ
Biomaterials; 2012 Feb; 33(5):1455-61. PubMed ID: 22078812
[TBL] [Abstract][Full Text] [Related]
15. Additive Pharmacological Interaction between Cisplatin (CDDP) and Histone Deacetylase Inhibitors (HDIs) in MDA-MB-231 Triple Negative Breast Cancer (TNBC) Cells with Altered Notch1 Activity-An Isobolographic Analysis.
Wawruszak A; Luszczki JJ; Kalafut J; Okla K; Halasa M; Rivero-Muller A; Stepulak A
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357442
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholesterol concentration on the interaction of cytarabine with lipid membranes: a molecular dynamics simulation study.
Karami L; Jalili S
J Biomol Struct Dyn; 2015; 33(6):1254-68. PubMed ID: 25068451
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of in vivo anticancer effects of cisplatin by incorporation inside single-wall carbon nanohorns.
Ajima K; Murakami T; Mizoguchi Y; Tsuchida K; Ichihashi T; Iijima S; Yudasaka M
ACS Nano; 2008 Oct; 2(10):2057-64. PubMed ID: 19206452
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin loaded methoxy poly (ethylene glycol)-block-Poly (L-glutamic acid-co-L-Phenylalanine) nanoparticles against human breast cancer cell.
Ahmad Z; Tang Z; Shah A; Lv S; Zhang D; Zhang Y; Chen X
Macromol Biosci; 2014 Sep; 14(9):1337-45. PubMed ID: 24933015
[TBL] [Abstract][Full Text] [Related]
19. Near-infrared light stimuli-responsive synergistic therapy nanoplatforms based on the coordination of tellurium-containing block polymer and cisplatin for cancer treatment.
Li F; Li T; Cao W; Wang L; Xu H
Biomaterials; 2017 Jul; 133():208-218. PubMed ID: 28441615
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect.
Saisyo A; Nakamura H; Fang J; Tsukigawa K; Greish K; Furukawa H; Maeda H
Colloids Surf B Biointerfaces; 2016 Feb; 138():128-37. PubMed ID: 26674841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
